| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
|
Am J Psychiatry
|
2014
|
2.43
|
|
2
|
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
|
Am J Psychiatry
|
2010
|
2.41
|
|
3
|
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
|
Am J Psychiatry
|
2013
|
1.97
|
|
4
|
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder.
|
Eur Arch Psychiatry Clin Neurosci
|
2012
|
1.49
|
|
5
|
Genetic predictors of response to antidepressants in the GENDEP project.
|
Pharmacogenomics J
|
2009
|
1.35
|
|
6
|
Noradrenaline in mood and anxiety disorders: basic and clinical studies.
|
Int Clin Psychopharmacol
|
2003
|
1.34
|
|
7
|
Moderation of antidepressant response by the serotonin transporter gene.
|
Br J Psychiatry
|
2009
|
1.25
|
|
8
|
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study.
|
Int Clin Psychopharmacol
|
2006
|
1.21
|
|
9
|
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.
|
PLoS Med
|
2012
|
1.19
|
|
10
|
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.
|
Br J Psychiatry
|
2009
|
1.13
|
|
11
|
Adverse reactions to antidepressants.
|
Br J Psychiatry
|
2009
|
1.12
|
|
12
|
Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression.
|
Neuropsychopharmacology
|
2006
|
1.12
|
|
13
|
Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
|
Neuropsychopharmacology
|
2009
|
1.04
|
|
14
|
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
|
J Affect Disord
|
2011
|
1.03
|
|
15
|
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
|
Int Clin Psychopharmacol
|
2011
|
0.97
|
|
16
|
Body weight as a predictor of antidepressant efficacy in the GENDEP project.
|
J Affect Disord
|
2009
|
0.96
|
|
17
|
Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants.
|
Biol Psychiatry
|
2010
|
0.96
|
|
18
|
Dissecting the genetic heterogeneity of depression through age at onset.
|
Am J Med Genet B Neuropsychiatr Genet
|
2012
|
0.93
|
|
19
|
Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study.
|
Eur J Hum Genet
|
2004
|
0.93
|
|
20
|
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
|
BMC Med
|
2009
|
0.91
|
|
21
|
Genetic differences in cytochrome P450 enzymes and antidepressant treatment response.
|
J Psychopharmacol
|
2013
|
0.91
|
|
22
|
Rare copy number variants in neuropsychiatric disorders: Specific phenotype or not?
|
Am J Med Genet B Neuropsychiatr Genet
|
2012
|
0.90
|
|
23
|
Current issues in bipolar disorder: a critical review.
|
Eur Neuropsychopharmacol
|
2007
|
0.89
|
|
24
|
Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.
|
J Psychopharmacol
|
2011
|
0.88
|
|
25
|
No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: evidence from Belgian first and replication patient-control studies.
|
Eur Neuropsychopharmacol
|
2005
|
0.88
|
|
26
|
Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study.
|
Am J Med Genet B Neuropsychiatr Genet
|
2004
|
0.87
|
|
27
|
Changes in body weight during pharmacological treatment of depression.
|
Int J Neuropsychopharmacol
|
2010
|
0.87
|
|
28
|
The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
|
Int Clin Psychopharmacol
|
2010
|
0.86
|
|
29
|
Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd).
|
Int J Neuropsychopharmacol
|
2013
|
0.86
|
|
30
|
European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings.
|
Eur Neuropsychopharmacol
|
2012
|
0.86
|
|
31
|
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients.
|
Int Clin Psychopharmacol
|
2009
|
0.84
|
|
32
|
Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder.
|
Eur Arch Psychiatry Clin Neurosci
|
2012
|
0.84
|
|
33
|
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
|
Int Clin Psychopharmacol
|
2010
|
0.83
|
|
34
|
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2013
|
0.81
|
|
35
|
Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.
|
J Clin Psychiatry
|
2006
|
0.81
|
|
36
|
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
|
J Affect Disord
|
2011
|
0.81
|
|
37
|
COMT and age at onset in mood disorders: a replication and extension study.
|
Neurosci Lett
|
2011
|
0.81
|
|
38
|
Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression.
|
Am J Med Genet
|
2002
|
0.81
|
|
39
|
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.
|
Neuropsychobiology
|
2012
|
0.81
|
|
40
|
Variation in GNB3 predicts response and adverse reactions to antidepressants.
|
J Psychopharmacol
|
2010
|
0.80
|
|
41
|
History of suicide attempts among patients with depression in the GENDEP project.
|
J Affect Disord
|
2009
|
0.79
|
|
42
|
Dissociation in major depressive disorder: a pilot study.
|
J Trauma Dissociation
|
2008
|
0.79
|
|
43
|
Identification of a CACNA2D4 deletion in late onset bipolar disorder patients and implications for the involvement of voltage-dependent calcium channels in psychiatric disorders.
|
Am J Med Genet B Neuropsychiatr Genet
|
2012
|
0.79
|
|
44
|
Family history of major depression and residual symptoms in responder and non-responder depressed patients.
|
Compr Psychiatry
|
2013
|
0.79
|
|
45
|
Genetic association between the phospholipase A2 gene and unipolar affective disorder: a multicentre case-control study.
|
Psychiatr Genet
|
2003
|
0.79
|
|
46
|
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression.
|
Neurosci Lett
|
2012
|
0.78
|
|
47
|
Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients.
|
J Neural Transm (Vienna)
|
2014
|
0.78
|
|
48
|
Patient-control association study of substance P-related genes in unipolar and bipolar affective disorders.
|
Int J Neuropsychopharmacol
|
2005
|
0.78
|
|
49
|
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
|
World J Biol Psychiatry
|
2011
|
0.78
|
|
50
|
Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.
|
Psychiatry Res
|
2007
|
0.78
|
|
51
|
Molecular genetics of affective disorders.
|
Int J Neuropsychopharmacol
|
2003
|
0.77
|
|
52
|
Mixed, melancholic, and anxious features in depression: a cross-sectional study of sociodemographic and clinical correlates.
|
Ann Clin Psychiatry
|
2014
|
0.77
|
|
53
|
Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients.
|
J Affect Disord
|
2013
|
0.77
|
|
54
|
Exploring the role of drug-metabolising enzymes in antidepressant side effects.
|
Psychopharmacology (Berl)
|
2015
|
0.77
|
|
55
|
Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders.
|
Am J Med Genet
|
2002
|
0.77
|
|
56
|
Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression.
|
Int J Neurosci
|
2014
|
0.77
|
|
57
|
Fluvoxamine-induced hyperglycaemia in a diabetic patient with comorbid depression.
|
Int J Neuropsychopharmacol
|
2003
|
0.76
|
|
58
|
Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study.
|
Int Clin Psychopharmacol
|
2010
|
0.76
|
|
59
|
The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment - a European multicentre study.
|
Int Clin Psychopharmacol
|
2016
|
0.76
|
|
60
|
The impact of adverse life events on clinical features and interaction with gene variants in mood disorder patients.
|
Psychopathology
|
2013
|
0.76
|
|
61
|
Lack of genetic association between the phospholipase A2 gene and bipolar mood disorder in a European multicentre case-control study.
|
Psychiatr Genet
|
2006
|
0.75
|
|
62
|
Genome-wide association study of co-occurring anxiety in major depression.
|
World J Biol Psychiatry
|
2013
|
0.75
|
|
63
|
Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study.
|
Eur Neuropsychopharmacol
|
2003
|
0.75
|
|
64
|
Social adjustment among treatment responder patients with mood disorders.
|
J Affect Disord
|
2013
|
0.75
|
|
65
|
Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features.
|
Ann Clin Psychiatry
|
2013
|
0.75
|
|
66
|
Molecular genetics of affective disorders.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2004
|
0.75
|
|
67
|
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
|
Psychiatry Res
|
2010
|
0.75
|
|
68
|
Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
|
J Psychopharmacol
|
2014
|
0.75
|
|
69
|
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples.
|
J Psychopharmacol
|
2013
|
0.75
|
|
70
|
Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
|
World J Biol Psychiatry
|
2010
|
0.75
|
|
71
|
Expanded RED products and loci containing CAG/CTG repeats on chromosome 17 (ERDA1) and chromosome 18 (CTG18.1) in trans-generational pairs with bipolar affective disorder.
|
Am J Med Genet B Neuropsychiatr Genet
|
2004
|
0.75
|